The most trusted news from Massachusetts

Provided by AGP

Got News to Share?

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on May 18, 2026

Breaking Down Barriers: Northeast Health Services Brings Mental Health Services to Billerica
Visology Announces Expansion Across Greater Boston Through Its Relationship with Stop & Shop Beginning Spring 2026
Jedox strengthens its platform for the AI era with the Jedox 26 major release
TelluBase Edición Semestral H1 2026 Ya Disponible por Tellusant
EyeCool Therapeutics Announces Publication of First Randomized Controlled Trial of Novel Cooling Device for COSP
Access Fixtures Launches New ORBE Field-Selectable Architectural Dome-Top LED Louvered Bollard Light
Rare Stamp Discovery Worth Millions to be Offered at Auction for the First Time
Schylling Shares NeeDoh Safety and Retail Guidance Amid High Demand
Cullinan Therapeutics to Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 Congress
 Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing
Precision Optics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Akamai Announces Proposed Offering of Convertible Senior Notes
Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference
Store Closing Sales Underway at Warehouse One and Bootlegger
Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
Atlas Copco Transforms Supply Chain Planning with ToolsGroup
Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participants with CRSwNP and Comorbid Asthma at the ATS 2026 International Conference

Share us

on your social networks:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.